CXCL3



CXCL3

S1SS1E2EE2L3LL3R4RR4C5CC5Q6QQ6C7CC7L8LL8N9NN9T10TT10L11LL11P12PP12R13RR13V14VV14D15DD15F16FF16E17EE17T18TT18I19II19Q20QQ20S21SS21L22LL22T23TT23V24VV24T25TT25P26PP26P27PP27G28GG28P29PP29H30HH30C31CC31T32TT32Q33QQ33T34TT34E35EE35V36VV36I37II37A38AA38T39TT39L40LL40K41KK41D42DD42G43GG43Q44QQ44E45EE45V46VV46C47CC47... and 22 more residue(s)...... and 22 more residue(s)

SMILES None
InChIKey None
Sequence SELRCQCLNTLPRVDFETIQSLTVTPPGPHCTQTEVIATLKDGQEVCLNPQGPRLQIIIKKILKSGKSS

Chemical Properties

Hydrogen bond acceptors None
Hydrogen bond donors None
Rotatable bonds None
Molecular weight (Da)

Database connections



No bioactivity data available.

CXCL3

S1SS1E2EE2L3LL3R4RR4C5CC5Q6QQ6C7CC7L8LL8N9NN9T10TT10L11LL11P12PP12R13RR13V14VV14D15DD15F16FF16E17EE17T18TT18I19II19Q20QQ20S21SS21L22LL22T23TT23V24VV24T25TT25P26PP26P27PP27G28GG28P29PP29H30HH30C31CC31T32TT32Q33QQ33T34TT34E35EE35V36VV36I37II37A38AA38T39TT39L40LL40K41KK41D42DD42G43GG43Q44QQ44E45EE45V46VV46C47CC47... and 22 more residue(s)...... and 22 more residue(s)

Drug properties

Molecular type Peptide
Physiological/Surrogate Endogenous
Approved drug No

Distribution across phases (no. indications)

Phase I 0
Phase II 0
Phase III 0
Phase IV 0

Database connections



Compound is not listed as a drug.